UK Stocks-Factors to watch on September 29
Sept 29 - Britain's FTSE 100 .FTSE index is seen opening higher on Monday, with futures FFIc1 up 0.39%.
DRUGMAKERS: The British government will offer to pay more for medicines that it buys for the National Health Service, the Financial Times reported on Friday, after U.S. President Donald Trump announced steep tariff increases on branded medication.
JLR: Britain will back Jaguar Land Rover with a 1.5 billion pound ($2 billion) loan guarantee to help support its supply chain in the wake of the luxury carmaker's production shutdown following a cyberattack.
JOB MARKET: Britain's labour market is showing more signs of cooling and businesses remain negative about their prospects in the coming months, according to surveys published on Monday.
ASTRAZENECA: Biotech company Factor Bioscience sued Cellectis ALCLS.PA and AstraZeneca AZN.L in Delaware federal court on Friday for allegedly infringing three patents related to gene-editing technology used in cancer treatments.
STANDARD CHARTERED: A U.S. judge on Friday dismissed two lawsuits seeking to hold Standard Chartered Bank STAN.L liable for having allegedly provided indirect support to groups that conducted 12 attacks in Israel and Iraq between 2010 and 2019.
OIL: Oil prices fell on Monday after Iraq's Kurdistan region resumed crude oil exports via Turkey and as OPEC+ plans another oil output hike in November.
GOLD: Gold surged above the key $3,800-per-ounce level for the first time ever on Monday, supported by a weaker dollar and growing expectations that the Federal Reserve will cut interest rates further this year.
FTSE: UK's FTSE 100 <.FTSE > rose 0.8% on Friday, led by banks and consumer discretionary shares, while investors showed little reaction to fresh tariff threats.
For more on the factors affecting European stocks, please click on: LIVE/
TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB
Recommended Articles













Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.